Capital World Investors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,631,547
Closed -$18.5M 585
2022
Q2
$18.5M Hold
1,631,547
﹤0.01% 466
2022
Q1
$36.4M Hold
1,631,547
0.01% 447
2021
Q4
$71.3M Buy
1,631,547
+431,547
+36% +$17.3M 0.01% 399
2021
Q3
$40M Hold
1,200,000
0.01% 481
2021
Q2
$33M Hold
1,200,000
0.01% 496
2021
Q1
$24.1M Hold
1,200,000
﹤0.01% 505
2020
Q4
$39.6M Buy
1,200,000
+194,954
+19% +$5.19M 0.01% 433
2020
Q3
$18.1M Buy
+1,005,046
New +$18.2M ﹤0.01% 477

Other funds holding INBX

Capital World Investors's INBX Position: Q3 2022 in Review

Capital World Investors sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2022, closing a stake of 1,631,547 shares — an estimated $18.5M sold.

Capital World Investors first reported a position in INBX in Q3 2020 and held it in 8 quarters. The position peaked at $71.3M in Q4 2021. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2022.

  • Capital World Investors reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Capital World Investors sold 1,631,547 Inhibrx, Inc. Common Stock shares in Q3 2022, an estimated $18.5M.
  • Capital World Investors first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Capital World Investors's Inhibrx, Inc. Common Stock position peaked at $71.3M in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.